CAGAS
FLGT icon

Capital Advisory Group Advisory Services’s Fulgent Genetics FLGT Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19
Closed -$2K – 276
2021
Q3 		$2K Buy
+19
New +$1.73K ﹤0.01% 499

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital Advisory Group Advisory Services's FLGT Position: Q4 2021 in Review

Capital Advisory Group Advisory Services sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 19 shares — an estimated $2K sold.

Capital Advisory Group Advisory Services first reported a position in FLGT in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

  • Capital Advisory Group Advisory Services reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 19 Fulgent Genetics shares in Q4 2021, an estimated $2K.
  • Capital Advisory Group Advisory Services first reported a position in Fulgent Genetics in Q3 2021 and held it in 1 quarter.
  • Capital Advisory Group Advisory Services's Fulgent Genetics position peaked at $2K in Q3 2021.
  • 299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2021, filed 15 Feb 2022.